Q01167 (FOXK2_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 144.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Forkhead box protein K2 Alternative name(s): Cellular transcription factor ILF-1 FOXK1 Interleukin enhancer-binding factor 1 | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 660 AA. |
| Sequence status | Complete. |
| Sequence processing | The displayed sequence is further processed into a mature form. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Recognizes the core sequence 5'-TAAACA-3'. Binds to NFAT-like motifs (purine-rich) in the IL2 promoter. Also binds to HIV-1 long terminal repeat. May be involved in both positive and negative regulation of important viral and cellular promoter elements. Ref.1 Ref.2 |
| Cofactor | Binds 1 magnesium ion per subunit. Ref.12 |
| Subcellular location | Nucleus Probable. |
| Tissue specificity | Expressed in both lymphoid and non-lymphoid cells. Ref.2 |
| Domain | The C-terminal part of the DNA-binding domain may contribute to DNA recognition specificity. Ref.12 |
| Sequence similarities | Contains 1 FHA domain. Contains 1 fork-head DNA-binding domain. |
| Sequence caution | The sequence AAB02820.1 differs from that shown. Reason: The N-terminal sequence differs due to frameshifts and sequencing errors. The sequence AAB02821.1 differs from that shown. Reason: The N-terminal sequence differs due to frameshifts and sequencing errors. The sequence AAB02822.1 differs from that shown. Reason: The N-terminal sequence differs due to frameshifts and sequencing errors. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| IRF2 | P14316 | 2 | EBI-2509991,EBI-2866589 |
Alternative products
| This entry describes 3 isoforms produced by alternative splicing. [Align] [Select] | ||||||
| Isoform 1 (identifier: Q01167-1) This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry. | ||||||
| Isoform 2 (identifier: Q01167-2) The sequence of this isoform differs from the canonical sequence as follows: 596-660: AAASPLHMLA...AAVREKGVQN → GPLGLRRPPCASSDWSCLS | ||||||
| Isoform 3 (identifier: Q01167-3) The sequence of this isoform differs from the canonical sequence as follows: 304-328: NSIRHNLSLNRYFIKVPRSQEEPGK → RGESFAHVGNTRIRIGLPAHKAPQR 329-660: Missing. |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | ||||||||||||||||||||||
Molecule processing | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Initiator methionine | 1 | 1 | Removed Ref.9 | ||||||||||||||||||||||||
| Chain | 2 – 660 | 659 | Forkhead box protein K2 | PRO_0000091858 | |||||||||||||||||||||||
Regions | |||||||||||||||||||||||||||
| Domain | 54 – 128 | 75 | FHA | ||||||||||||||||||||||||
| DNA binding | 258 – 353 | 96 | Fork-head Ref.11 Ref.12 | ||||||||||||||||||||||||
| Region | 300 – 318 | 19 | DNA-binding; major groove | ||||||||||||||||||||||||
| Region | 328 – 332 | 5 | DNA-binding; minor groove | ||||||||||||||||||||||||
| Region | 348 – 353 | 6 | DNA-binding; minor groove | ||||||||||||||||||||||||
| Compositional bias | 10 – 93 | 84 | Gly-rich | ||||||||||||||||||||||||
Sites | |||||||||||||||||||||||||||
| Metal binding | 310 | 1 | Magnesium; via carbonyl oxygen | ||||||||||||||||||||||||
| Metal binding | 311 | 1 | Magnesium; via carbonyl oxygen | ||||||||||||||||||||||||
| Metal binding | 313 | 1 | Magnesium; via carbonyl oxygen | ||||||||||||||||||||||||
| Metal binding | 316 | 1 | Magnesium; via carbonyl oxygen | ||||||||||||||||||||||||
Amino acid modifications | |||||||||||||||||||||||||||
| Modified residue | 2 | 1 | N-acetylalanine Ref.9 | ||||||||||||||||||||||||
| Modified residue | 30 | 1 | Phosphoserine Ref.9 | ||||||||||||||||||||||||
| Modified residue | 239 | 1 | Phosphoserine Ref.5 | ||||||||||||||||||||||||
| Modified residue | 398 | 1 | Phosphoserine Ref.8 Ref.9 Ref.10 | ||||||||||||||||||||||||
| Modified residue | 424 | 1 | Phosphoserine Ref.9 | ||||||||||||||||||||||||
| Modified residue | 428 | 1 | Phosphoserine Ref.6 Ref.8 Ref.9 | ||||||||||||||||||||||||
Natural variations | |||||||||||||||||||||||||||
| Alternative sequence | 304 – 328 | 25 | NSIRH…EEPGK → RGESFAHVGNTRIRIGLPAH KAPQR in isoform 3. | VSP_001560 | |||||||||||||||||||||||
| Alternative sequence | 329 – 660 | 332 | Missing in isoform 3. | VSP_001561 | |||||||||||||||||||||||
| Alternative sequence | 596 – 660 | 65 | AAASP…KGVQN → GPLGLRRPPCASSDWSCLS in isoform 2. | VSP_001559 | |||||||||||||||||||||||
Experimental info | |||||||||||||||||||||||||||
| Mutagenesis | 258 | 1 | K → A: Decreases DNA-binding to 40%. Ref.12 | ||||||||||||||||||||||||
| Mutagenesis | 300 | 1 | K → A: Decreases DNA-binding to 20%. Ref.12 | ||||||||||||||||||||||||
| Mutagenesis | 305 | 1 | S → A: Decreases DNA-binding to 70%. Ref.12 | ||||||||||||||||||||||||
| Mutagenesis | 307 | 1 | R → A: Abolishes DNA-binding. Ref.12 | ||||||||||||||||||||||||
| Mutagenesis | 328 | 1 | K → A: Decreases DNA-binding to 25%. Ref.12 | ||||||||||||||||||||||||
| Sequence conflict | 3 – 120 | 118 | AAAAA…LGKNG → Q in CAA43200. Ref.1 | ||||||||||||||||||||||||
Secondary structure | |||||||||||||||||||||||||||
Helix Strand Turn | |||||||||||||||||||||||||||
| Helix | 263 – 272 | 10 | |||||||||||||||||||||||||
| Beta strand | 277 – 279 | 3 | |||||||||||||||||||||||||
| Helix | 281 – 291 | 11 | |||||||||||||||||||||||||
| Beta strand | 295 – 298 | 4 | |||||||||||||||||||||||||
| Helix | 300 – 312 | 13 | |||||||||||||||||||||||||
| Beta strand | 316 – 319 | 4 | |||||||||||||||||||||||||
| Beta strand | 324 – 329 | 6 | |||||||||||||||||||||||||
| Beta strand | 331 – 334 | 4 | |||||||||||||||||||||||||
| Helix | 336 – 346 | 11 | |||||||||||||||||||||||||
Sequences
| ||||||||||||||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Cloning of a cellular factor, interleukin binding factor, that binds to NFAT-like motifs in the human immunodeficiency virus long terminal repeat." Li C., Lai C., Sigman D.S., Gaynor R.B. Proc. Natl. Acad. Sci. U.S.A. 88:7739-7743(1991) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION. Tissue: Cervix carcinoma. |
| [2] | "Characterization and chromosomal mapping of the gene encoding the cellular DNA binding protein ILF." Li C., Lusis A.J., Sparkes R., Nirula A., Gaynor R.B. Genomics 13:665-671(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE SPECIFICITY. Tissue: Cervix carcinoma and Lymphoid tissue. |
| [3] | Nirula A., Moore D.J., Li C., Gaynor R.B. Submitted (MAY-1996) to the EMBL/GenBank/DDBJ databases Cited for: SEQUENCE REVISION (ISOFORMS 1; 2 AND 3). |
| [4] | "DNA sequence of human chromosome 17 and analysis of rearrangement in the human lineage." Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R., Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A., Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J., Chang J.L. Nusbaum C.Nature 440:1045-1049(2006) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | "ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage." Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E., Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y., Gygi S.P., Elledge S.J. Science 316:1160-1166(2007) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-239, MASS SPECTROMETRY. Tissue: Embryonic kidney. |
| [6] | "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient phosphoproteomic analysis." Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III J. Proteome Res. 7:1346-1351(2008) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-428, MASS SPECTROMETRY. Tissue: Cervix carcinoma. |
| [7] | "A quantitative atlas of mitotic phosphorylation." Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. Tissue: Cervix carcinoma. |
| [8] | "Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions." Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K. Sci. Signal. 2:RA46-RA46(2009) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-398 AND SER-428, MASS SPECTROMETRY. Tissue: Leukemic T-cell. |
| [9] | "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis." Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract] Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-30; SER-398; SER-424 AND SER-428, MASS SPECTROMETRY, CLEAVAGE OF INITIATOR METHIONINE. Tissue: Cervix carcinoma. |
| [10] | "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation." Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B. Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract] Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-398, MASS SPECTROMETRY. |
| [11] | "Solution structure of the DNA-binding domain of interleukin enhancer binding factor 1 (FOXK1a)." Liu P.-P., Chen Y.-C., Li C., Hsieh Y.-H., Chen S.-W., Chen S.-H., Jeng W.-Y., Chuang W.-J. Proteins 49:543-553(2002) [PubMed] [Europe PMC] [Abstract] Cited for: STRUCTURE BY NMR OF 256-353 (ISOFORM 1), DNA-BINDING. |
| [12] | "Crystal structure of the human FOXK1a-DNA complex and its implications on the diverse binding specificity of winged helix/forkhead proteins." Tsai K.-L., Huang C.-Y., Chang C.-H., Sun Y.-J., Chuang W.-J., Hsiao C.-D. J. Biol. Chem. 281:17400-17409(2006) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.40 ANGSTROMS) OF 256-353 (ISOFORM 1) IN COMPLEX WITH MAGNESIUM AND DUPLEX DNA, DNA-BINDING, COFACTOR, DOMAIN, MUTAGENESIS OF LYS-258; LYS-300; SER-305; ARG-307 AND LYS-328. |
Cross-references
Sequence databases | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X60787 mRNA. Translation: CAA43200.1. U58196 mRNA. Translation: AAB02820.1. Sequence problems. U58197 mRNA. Translation: AAB02821.1. Sequence problems. U58198 mRNA. Translation: AAB02822.1. Sequence problems. AC124287 Genomic DNA. No translation available. | ||||||||||||||||||
| IPI | IPI00006029. IPI00220426. IPI00479612. | ||||||||||||||||||
| PIR | A41285. | ||||||||||||||||||
| RefSeq | NP_004505.2. NM_004514.3. | ||||||||||||||||||
| UniGene | Hs.591140. | ||||||||||||||||||
3D structure databases | |||||||||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||||||||
| ProteinModelPortal | Q01167. | ||||||||||||||||||
| ModBase | Search... | ||||||||||||||||||
Protein-protein interaction databases | |||||||||||||||||||
| IntAct | Q01167. 9 interactions. | ||||||||||||||||||
| STRING | 9606.ENSP00000335677. | ||||||||||||||||||
PTM databases | |||||||||||||||||||
| PhosphoSite | Q01167. | ||||||||||||||||||
Polymorphism databases | |||||||||||||||||||
| DMDM | 118572648. | ||||||||||||||||||
Proteomic databases | |||||||||||||||||||
| PaxDb | Q01167. | ||||||||||||||||||
| PRIDE | Q01167. | ||||||||||||||||||
Protocols and materials databases | |||||||||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||||||||
Genome annotation databases | |||||||||||||||||||
| Ensembl | ENST00000335255; ENSP00000335677; ENSG00000141568. ENST00000473637; ENSP00000436108; ENSG00000141568. | ||||||||||||||||||
| GeneID | 3607. | ||||||||||||||||||
| KEGG | hsa:3607. | ||||||||||||||||||
| UCSC | uc002kfm.1. human. uc002kfn.3. human. uc010diu.3. human. | ||||||||||||||||||
Organism-specific databases | |||||||||||||||||||
| CTD | 3607. | ||||||||||||||||||
| GeneCards | GC17P080477. | ||||||||||||||||||
| H-InvDB | HIX0014279. | ||||||||||||||||||
| HGNC | HGNC:6036. FOXK2. | ||||||||||||||||||
| HPA | HPA027523. | ||||||||||||||||||
| MIM | 147685. gene. | ||||||||||||||||||
| neXtProt | NX_Q01167. | ||||||||||||||||||
| PharmGKB | PA29851. | ||||||||||||||||||
| GenAtlas | Search... | ||||||||||||||||||
Phylogenomic databases | |||||||||||||||||||
| eggNOG | COG5025. | ||||||||||||||||||
| HOGENOM | HOG000072588. | ||||||||||||||||||
| HOVERGEN | HBG051649. | ||||||||||||||||||
| InParanoid | Q01167. | ||||||||||||||||||
| KO | K09404. | ||||||||||||||||||
| OMA | HGQVNNA. | ||||||||||||||||||
| OrthoDB | EOG4XD3QX. | ||||||||||||||||||
| PhylomeDB | Q01167. | ||||||||||||||||||
Gene expression databases | |||||||||||||||||||
| ArrayExpress | Q01167. | ||||||||||||||||||
| Bgee | Q01167. | ||||||||||||||||||
| CleanEx | HS_FOXK2. | ||||||||||||||||||
| Genevestigator | Q01167. | ||||||||||||||||||
| GermOnline | ENSG00000141568. Homo sapiens. | ||||||||||||||||||
Family and domain databases | |||||||||||||||||||
| Gene3D | 1.10.10.10. 1 hit. 2.60.200.20. 1 hit. | ||||||||||||||||||
| InterPro | IPR000253. FHA_dom. IPR008984. SMAD_FHA_domain. IPR001766. TF_fork_head. IPR018122. TF_fork_head_CS. IPR011991. WHTH_DNA-bd_dom. [Graphical view] | ||||||||||||||||||
| Pfam | PF00498. FHA. 1 hit. PF00250. Fork_head. 1 hit. [Graphical view] | ||||||||||||||||||
| PRINTS | PR00053. FORKHEAD. | ||||||||||||||||||
| SMART | SM00339. FH. 1 hit. SM00240. FHA. 1 hit. [Graphical view] | ||||||||||||||||||
| SUPFAM | SSF49879. SMAD_FHA. 1 hit. | ||||||||||||||||||
| PROSITE | PS50006. FHA_DOMAIN. 1 hit. PS00657. FORK_HEAD_1. 1 hit. PS00658. FORK_HEAD_2. 1 hit. PS50039. FORK_HEAD_3. 1 hit. [Graphical view] | ||||||||||||||||||
| ProtoNet | Search... | ||||||||||||||||||
Other | |||||||||||||||||||
| ChiTaRS | FOXK2. human. | ||||||||||||||||||
| EvolutionaryTrace | Q01167. | ||||||||||||||||||
| GenomeRNAi | 3607. | ||||||||||||||||||
| NextBio | 14097. | ||||||||||||||||||
| SOURCE | Search... | ||||||||||||||||||
Entry information
| Entry name | FOXK2_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q01167 Secondary accession number(s): A6NEP5 Q13624 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 17 Human chromosome 17: entries, gene names and cross-references to MIM |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
